Commission Regulation (EC) No 507/2006 of 29 March 2006 on the conditional marketing authorisation for medicinal products for human use falling within the scope of Regulation (EC) No 726/2004 of the European Parliament and of the Council
Proposed act with possible EEA relevance
Act under scrutiny by EEA EFTA
Draft Joint Committee Decision (JCD) under consideration
Entry into force of Joint Committee Decision (JCD) pending
Incorporated into the EEA Agreement and in force
Incorporated into the EEA Agreement but no longer in force
Legal status
EU legal act incorporated into the EEA Agreement by a Joint Committee Decision (JCD)
Area (EEA Agreement)
II Technical Regulations, Standards, Testing and Certification
II.XIII Medicinal Products
Joint committee decision (JCD)
061/2009
In force in the EEA
Yes
Legal Documents
Commission Regulation (EC) No 507/2006 of 29 March 2006 on the conditional marketing authorisation for medicinal products for human use falling within the scope of Regulation (EC) No 726/2004 of the European Parliament and of the Council
Reglugerð framkvæmdastjórnarinnar (EB) nr. 507/2006 frá 29. mars 2006 um skilyrt markaðsleyfi fyrir mannalyfjum sem falla undir gildissvið reglugerðar Evrópuþingsins og ráðsins (EB) nr. 726/2004
Verordnung (EG) Nr. 507/2006 der Kommission vom 29. März 2006 über die bedingte Zulassung von Humanarzneimitteln, die unter den Geltungsbereich der Verordnung (EG) Nr. 726/2004 des Europäischen Parlaments und des Rates fallen
Kommisjonsforordning (EF) nr. 507/2006 av 29. mars 2006 om betinget markedsføringstillatelse for legemidler for mennesker som omfattes av europaparlaments- og rådsforordning (EF) nr. 726/2004
History
Disclaimer: EEA-Lex is provided for information purposes only. The information is not guaranteed or promised to be current or complete and is not intended to replace any applicable legal sources.